Glenmark Pharmaceuticals has informed about a Press Release dated June 24, 2016 titled ‘Glenmark Pharmaceuticals receives ANDA approval for Nystatin and Triamcinolone Acetonide Ointment USP, 100,000 units/1 mg per gram’.
The above information is a part of company’s filings submitted to BSE.